| Lipid Composition for LDE-501 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-dodecyl-sn-glycero-3-phosphocholine | 10 mg/vial | 16.84 umol | 100 |
| Lipid Composition for LDE-502 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-tridecyl-sn-glycero-3-phosphocholine | 10 mg/vial | 16.08 umol | 100 |
| Lipid Composition for LDE-503 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-tetradecyl-sn-glycero-3-phosphocholine | 10 mg/vial | 15.39 umol | 100 |
| Lipid Composition for LDE-504 | Concentration (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-hexadecyl-sn-glycero-3-phosphocholine | 10 mg/vial | 14.16 umol | 100 |
| Lipid Composition for LDE-505 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-octadecyl-sn-glycero-3-phosphocholine | 10 mg/vial | 13.12 umol | 100 |
| Lipid Composition for LDE-506 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-(9Z-octadecenyl)-sn-glycero-3-phosphocholine | 10 mg/vial | 13.19 umol | 100 |
| Lipid Composition for LDE-507 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-dodecyl-sn-glycero-3-phosphocholine | 7.82 | 13.16 | 70 |
| Cholesterol | 2.18 | 5.64 | 30 |
| Total | 10.00 mg/vial | 18.80 umol | 100 |
| Lipid Composition for LDE-508 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-tridecyl-sn-glycero-3-phosphocholine | 7.90 | 12.70 | 70 |
| Cholesterol | 2.10 | 5.44 | 30 |
| Total | 10.00 mg/vial | 18.14 | 100 |
| Lipid Composition for LDE-509 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-tetradecyl-sn-glycero-3-phosphocholine | 7.97 | 12.26 | 70 |
| Cholesterol | 2.03 | 5.26 | 30 |
| Total | 10.00 mg/vial | 17.52 umol | 100 |
| Lipid Composition for LDE-510 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-hexadecyl-sn-glycero-3-phosphocholine | 8.10 | 11.47 | 70 |
| Cholesterol | 1.90 | 4.92 | 30 |
| Total | 10.00 mg/vial | 16.39 umol | 100 |
| Lipid Composition for LDE-511 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-octadecyl-sn-glycero-3-phosphocholine | 8.21 | 10.77 | 70 |
| Cholesterol | 1.79 | 4.62 | 30 |
| Total | 10.00 mg/vial | 15.39 umol | 100 |
| Lipid Composition for LDE-512 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-di-O-(9Z-octadecenyl)-sn-glycero-3-phosphocholine | 8.21 | 10.83 | 70 |
| Cholesterol | 1.79 | 4.64 | 30 |
| Total | 10.00 mg/vial | 15.47 umol | 100 |
